Medical Sciences Stack Exchange is a question and answer site for professionals in medical and allied health fields, students of those professions, related academics, and others with a sound understanding of medicine and healthcare-related sciences. It only takes a minute to sign up.
Sign up to join this community
5HT3 Inhibitors are antiemetics, such as Mirtazapine. See here and here
The serotonin modulator vortioxetine is such an inhibitor, and the most common side effect is nausea, in 3 it says that it has a 5HT3-inhibitor effect.
I am confused. Can someone explain the contradiction between explanations?
Its primary action is as NaSSA (a noradrenergic and specific serotonergic antidepressant), not as 5-HT3 inhibitor. If you have a look at e. g. the Wikipedia page (https://en.wikipedia.org/wiki/Mirtazapine#Pharmacodynamics), you will see that nausea is listed as side effect under "discontinuation syndrome", i. e. sudden withdrawal from continuous 5-HT3 blocking. As a side note, it also has H1-blocking effects, which are antiemetic as well.
There are more withdrawal symptoms listed here: https://www.nami.org/About-Mental-Illness/Treatments/Mental-Health-Medications/Types-of-Medication/Mirtazapine-(Remeron)
I was mistaken, the 5HT3 inhibitor of Vortioxetine is not responsible for the nausea, see here
Its additional antagonism of 5-HT3 receptors may partly counteract gastrointestinal adverse effects but nausea has an important role on drug discontinuation.
His 5HTI agonist property contributes to Nausea.
Its additional antagonism of 5-HT3 receptors may partly counteract gastrointestinal adverse effects but nausea has an important role on drug discontinuation.
